Orchard Therapeutics plc (ORTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

108 CANNON STREET LONDON, UNITED KINGDOM EC4N 6EU

Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. The company's ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration. In 2018, Orchard acquired GSK's rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Orchard now has one of the deepest and most advanced gene therapy product candidate pipelines in the industry spanning multiple therapeutic areas where the disease burden on children, families and caregivers is immense and current treatment options are limited or do not exist.

Data as of 2021-10-17 10:25:44 -0400
Market Cap273.308 Million Shares Outstanding125.371 Million Avg 30-day Volume1.496 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.23247 52-week High/Low9.08 / 2.0 Next Earnings Date2021-11-02 Price to Cash FLow (P/CF) -9.8042
Data provided by IEX Cloud
View SEC Filings from ORTX instead.

View recent insider trading info

Funds Holding ORTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ORTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GERAGHTY JAMES A

  • Director
40,000 2021-06-16 1

ROWLAND CHARLES A JR

  • Director
40,000 2021-06-16 1

ALTSCHULER STEVEN

  • Director
40,000 2021-06-16 1

CURNUTTE JOHN T

  • Director
40,000 2021-06-16 1

SECOR ALICIA

  • Director
40,000 2021-06-16 1

BECK JOANNE T.

  • Director
40,000 2021-06-16 1

DUNOYER MARC

  • Director
40,000 2021-06-16 1

FMR LLC

  • SEE REMARK 1
No longer subject to file 2021-03-09 3

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
No longer subject to file 2021-02-09 1

THOMAS FRANK E SEE REMARKS

  • Officer
0 2021-02-01 3

GASPAR BOBBY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-02-01 2

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
12,455,252 2020-01-01 0

ROTHERA MARK SEE REMARKS

  • Officer
  • Director
103,796 2020-01-01 0

ELLIS JON

  • Director
0 2020-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 22:15:03 UTC -0.7056 0.7756 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 21:45:03 UTC -0.7056 0.7756 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 21:15:03 UTC -0.7056 0.7756 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 20:45:03 UTC -0.7056 0.7756 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 20:15:03 UTC -0.7056 0.7756 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 19:45:03 UTC -0.7056 0.7756 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 19:15:03 UTC -0.7056 0.7756 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 18:45:03 UTC -0.7893 0.8593 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 18:15:03 UTC -0.7893 0.8593 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 17:45:03 UTC -0.7893 0.8593 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 17:15:03 UTC -0.7893 0.8593 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 16:45:03 UTC -0.4765 0.5465 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 16:15:04 UTC -0.4765 0.5465 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 15:45:03 UTC -0.4765 0.5465 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 15:15:03 UTC -0.4765 0.5465 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 14:45:03 UTC -0.4945 0.5645 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 14:15:03 UTC -0.4945 0.5645 1400000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 13:45:03 UTC -0.4945 0.5645 1400000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 13:15:03 UTC -0.4945 0.5645 1300000
ORCHARD THERAPEUTICS PLC-ADR ORTX 2021-10-22 12:45:03 UTC -0.4945 0.5645 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments